» Articles » PMID: 35819944

Investigating Latent Syphilis in HIV Treatment-experienced Ethiopians and Response to Therapy

Overview
Journal PLoS One
Date 2022 Jul 12
PMID 35819944
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We investigated people with HIV (PWH) receiving combination antiretroviral therapy (cART) for latent syphilis infection prevalence, risk factors, treatment response, and neurosyphilis.

Methods: A prospective follow-up study was conducted on PWH and latent syphilis. The cases were randomly assigned to receive either benzathine penicillin G (BPG) or doxycycline (DOXY), and the posttreatment response was evaluated after 12 and 24 months. The traditional algorithm was used for serodiagnosis, and a semi-quantitative rapid plasma reagin (RPR) test monitored disease activity and treatment effectiveness.

Results: Of the 823 participants, 64.8% were women, and the mean age was 41.7±10 years. Thirty-one (3.8%) of the participants (22 males and nine females) had latent syphilis. The risk factors were male sex (aOR = 3.14), increasing age (aOR = 1.04 per year), and cART duration (aOR = 1.01 per month). Baseline RPR titers were: ≤1:4 in 19 (61.3%), between 1:8 and 1:32 in 10 (32.2%), and >1:32 in 2 (6.4%). None of the seven cerebrospinal fluid analyses supported a neurosyphilis diagnosis. In the 12th month of treatment, 27 (87.1%) had adequate serological responses, three (9.7%) had serological nonresponse, and one (3.2%) had treatment failure. Syphilis treatment was repeated in the last four cases with the alternative drug. In terms of adequate serologic response, both therapies were comparable at the 12th month, p = 0.37. All cases responded to treatment in the 24th month.

Conclusion: In PWH receiving cART, latent syphilis occurred more in men than women, suggesting an investigation of sexual practices and the impact of antenatal syphilis screening. Syphilis disease activity reduces in the latent stage. Therefore, the routine cerebrospinal fluid analysis contributes little to the diagnosis of asymptomatic neurosyphilis and the treatment success of latent syphilis. DOXY is an alternative to BPG, and cART improves serologic response to latent syphilis treatment.

Citing Articles

Prevalence and Treatment Outcomes of Syphilis among People with Human Immunodeficiency Virus (HIV) Engaging in High-Risk Sexual Behavior: Real World Data from Northern Greece, 2019-2022.

Nanoudis S, Pilalas D, Tziovanaki T, Constanti M, Markakis K, Pagioulas K Microorganisms. 2024; 12(7).

PMID: 39065024 PMC: 11278651. DOI: 10.3390/microorganisms12071256.

References
1.
Stolte I, Dukers N, de Wit J, Fennema J, Coutinho R . Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART. Sex Transm Infect. 2001; 77(3):184-6. PMC: 1744315. DOI: 10.1136/sti.77.3.184. View

2.
Shimelis T, Lemma K, Ambachew H, Tadesse E . Syphilis among people with HIV infection in southern Ethiopia: sero-prevalence and risk factors. BMC Infect Dis. 2015; 15:189. PMC: 4406018. DOI: 10.1186/s12879-015-0919-7. View

3.
Nnoruka E, Ezeoke A . Evaluation of syphilis in patients with HIV infection in Nigeria. Trop Med Int Health. 2005; 10(1):58-64. DOI: 10.1111/j.1365-3156.2004.01344.x. View

4.
Ghanem K, Moore R, Rompalo A, Erbelding E, Zenilman J, Gebo K . Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS. 2008; 22(10):1145-51. PMC: 2553365. DOI: 10.1097/QAD.0b013e32830184df. View

5.
Zetola N, Klausner J . Syphilis and HIV infection: an update. Clin Infect Dis. 2007; 44(9):1222-8. DOI: 10.1086/513427. View